Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001897612-25-000236
Filing Date
2025-07-08
Accepted
2025-07-08 11:09:52
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5931
  Complete submission text file 0001897612-25-000236.txt   7753
Mailing Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808
Business Address 2711 CENTERVILLE ROAD SUITE 400 WILMINGTON DE 19808 (302) 252-9160
Enovis CORP (Subject) CIK: 0001420800 (see all company filings)

EIN.: 541887631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-84495 | Film No.: 251110058
SIC: 3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
(CF Office: 08 Industrial Applications and Services)

Mailing Address 1307 POINT STREET BALTIMORE MD 21231
Business Address 1307 POINT STREET BALTIMORE MD 21231 000-000-0000
T. Rowe Price Investment Management, Inc. (Filed by) CIK: 0001897612 (see all company filings)

EIN.: 854328500 | State of Incorp.: MD | Fiscal Year End: 1231
Type: SCHEDULE 13G/A